CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


tracheostomyWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (7)


Name (Synonyms) Correlation
drug2858 intubation Wiki 1.00
drug2562 Treatment with Dexmedetomidine Wiki 1.00
drug1064 High-flow nasal cannula Wiki 1.00
drug2913 nebulization Wiki 1.00
drug1949 Pulmonary function test Wiki 1.00
drug2385 Surgical mask Wiki 1.00
drug2772 bronchoscopy examination Wiki 1.00

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D003141 Communicable Diseases NIH 0.09
D007239 Infection NIH 0.06

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 An Observational Study to Investigate the Aerosol Particle Distribution During Aerosol Generating Procedures

Massive number of clinicians were infected during the outbreak of COVID-19, which raised the concerns of utilizing "aerosol generating procedures", particularly the use of high-flow nasal cannula, noninvasive ventilation, intubation, bronchoscopy examination and pulmonary function test. There appears to be a trend to avoid those treatments. Instead, aggressive intubation might cause shortage of medical devices and add extra workload. Therefore, we aimed to do a clinical observational study to evaluate the aerosol generation in these procedures and explore the potential measures to reduce the aerosol generation or dispersion.

NCT04353531 Transmission, Patient Professional High-flow Nasal Cannula Device: High-flow nasal cannula Device: Surgical mask Procedure: bronchoscopy examination Procedure: intubation Procedure: tracheostomy Device: nebulization Diagnostic Test: Pulmonary function test

Primary Outcomes

Description: The aerosol mass/count concentration pre procedure/treatment at 1 foot away from patient's airway in the patient's room

Measure: The aerosol mass/count concentration pre procedure/treatment at 1 foot away from patient

Time: 5 minutes before procedure/treatment

Description: The virus load in the air sample pre procedure/treatment at 1 foot away from patient's airway in the patient's room

Measure: The virus load in the air sample pre procedure/treatment at 1 foot away from patient

Time: 1 hour before procedure/treatment

Description: The virus load in the air sample during/after procedure/treatment at 1 foot away from patient's airway in the patient's room

Measure: The virus load in the air sample during/after procedure/treatment at 1 foot away from patient

Time: 1 hour during/after procedure/treatment

Description: The aerosol mass/count concentration pre procedure/treatment at 3 feet away from patient's airway in the patient's room

Measure: The aerosol mass/count concentration pre procedure/treatment at 3 feet away from patient

Time: 5 minutes before procedure/treatment

Description: The aerosol mass/count concentration and virus load in the air sample during procedure/treatment at 1 foot away from patient's airway in the patient's room

Measure: The aerosol mass/count concentration and virus load in the air sample during procedure/treatment at 1 foot away from patient

Time: during procedure/treatment

Description: The aerosol mass/count concentration during procedure/ treatment at 3 feet away from HFNC in the patient's room

Measure: The aerosol mass/count concentration during procedure/ treatment at 3 feet away from patient

Time: during procedure/treatment

Description: The aerosol mass/count concentration post procedure/ treatment at 1 foot away from HFNC in the patient's room

Measure: The aerosol mass/count concentration post procedure/ treatment at 1 foot away from patient

Time: 5 minutes post procedure/treatment

Description: The aerosol mass/count concentration 5 mins procedure/ treatment at 3 feet away from HFNC in the patient's room

Measure: The aerosol mass/count concentration 5 mins post procedure/ treatment at 3 feet away from patient

Time: 5 minutes post procedure/treatment


No related HPO nodes (Using clinical trials)